170 related articles for article (PubMed ID: 31727938)
1. Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cells.
Park SY; Lee DG; Jo A; Choi H; Lee JE; Jeong AJ; Leem SH; Jun W; Shim S; Ye SK; Min JK; Chung JW
Sci Rep; 2019 Nov; 9(1):16757. PubMed ID: 31727938
[TBL] [Abstract][Full Text] [Related]
2. Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties.
Zhao F; He X; Wang Y; Shi F; Wu D; Pan M; Li M; Wu S; Wang X; Dou J
Biosci Trends; 2015 Oct; 9(5):325-34. PubMed ID: 26559025
[TBL] [Abstract][Full Text] [Related]
3. Strategy of differentiation therapy: effect of dual-frequency ultrasound on the induction of liver cancer stem-like cells on a HA-based multilayer film system.
Lee IC; Fadera S; Liu HL
J Mater Chem B; 2019 Sep; 7(35):5401-5411. PubMed ID: 31414097
[TBL] [Abstract][Full Text] [Related]
4. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment.
Nair N; Calle AS; Zahra MH; Prieto-Vila M; Oo AKK; Hurley L; Vaidyanath A; Seno A; Masuda J; Iwasaki Y; Tanaka H; Kasai T; Seno M
Sci Rep; 2017 Jul; 7(1):6838. PubMed ID: 28754894
[TBL] [Abstract][Full Text] [Related]
5. Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential.
Li Y; Xie J; Du X; Chen Y; Wang C; Liu T; Yi Z; Wang Y; Zhao M; Li X; Shi S
Eur J Pharmacol; 2024 Jul; 975():176656. PubMed ID: 38754536
[TBL] [Abstract][Full Text] [Related]
6. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
[TBL] [Abstract][Full Text] [Related]
7. Identification of very small cancer stem cells expressing hallmarks of pluripotency in B16F10 melanoma cells and their reoccurrence in B16F10-derived clones.
Dias Câmara DA; Luiz de Sá Junior P; Alexandre de Azevedo R; Figueiredo CR; Araldi RP; Levy D; Madeiro de Souza D; Kerkis I
Exp Cell Res; 2020 Jun; 391(2):111938. PubMed ID: 32278688
[TBL] [Abstract][Full Text] [Related]
8. A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.
Sato Y; Yamada T; Hiroyama T; Sudo K; Hasegawa N; Hyodo I; Nakamura Y
Cancer Sci; 2019 May; 110(5):1644-1652. PubMed ID: 30784169
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma.
Ghosh S; Juin SK; Bhattacharyya Majumdar S; Majumdar S
Mol Carcinog; 2021 Dec; 60(12):840-858. PubMed ID: 34516706
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
12. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of cancer stem cell-like cells by culture in alginate gel beads.
Xu XX; Liu C; Liu Y; Yang L; Li N; Guo X; Sun GW; Ma XJ
J Biotechnol; 2014 May; 177():1-12. PubMed ID: 24607645
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
Fessler E; Dijkgraaf FE; De Sousa E Melo F; Medema JP
Cancer Lett; 2013 Nov; 341(1):97-104. PubMed ID: 23089245
[TBL] [Abstract][Full Text] [Related]
16. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
18. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
Kinugasa Y; Matsui T; Takakura N
Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
[TBL] [Abstract][Full Text] [Related]
19. Stem cells in breast tumours: are they ready for the clinic?
Ablett MP; Singh JK; Clarke RB
Eur J Cancer; 2012 Sep; 48(14):2104-16. PubMed ID: 22542086
[TBL] [Abstract][Full Text] [Related]
20. Sec23a inhibits the self-renewal of melanoma cancer stem cells via inactivation of ER-phagy.
Sun Z; Liu D; Zeng B; Zhao Q; Li X; Chen H; Wang J; Rosie Xing H
Cell Commun Signal; 2022 Mar; 20(1):22. PubMed ID: 35236368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
